
2028 年亚太地区医学影像市场预测 - COVID-19 影响和按产品进行区域分析(CT 系统、X 射线系统、PET 系统、MRI 系统、超声系统等);最终用户(医院、手术中心、临床医生办公室和紧急护理中心)
No. of Pages: 153 | Report Code: TIPRE00025110 | Category: Life Sciences
No. of Pages: 153 | Report Code: TIPRE00025110 | Category: Life Sciences
医学成像是指为诊断和治疗目的而创建人体各部位图像的技术和过程。数字健康。术语“医学成像”包括各种放射成像技术,例如:X 射线照相、透视、磁共振成像 (MRI)、医学超声检查或超声波、内窥镜检查、弹性成像、触觉成像、热成像、医学摄影和核医学功能成像技术例如,正电子发射断层扫描(PET)。医学成像在每个医疗环境和各个级别的医疗保健中都至关重要。
因此,对早期诊断的需求不断增加,预计将在未来几年对医学成像产生巨大的需求,并进一步预计这一需求将进一步增加。推动医学成像市场的发展。
COVID-19 大流行对该地区产生了严重影响,但它也为利益相关者提供了一个根据战略意图和重点重新调整未来道路的机会。此外,各个经济体一直在大力利用医学成像设备来诊断、评估、监测和规划 COVID-19 患者的治疗。据世界卫生组织 (WHO) 称,在印度、巴基斯坦、日本和该地区其他国家/地区,影像学也被认为可以补充管理已诊断为 COVID-19 的患者的临床评估和实验室参数。对有症状的患者使用医学成像来监测其治疗进展需要大量此类系统来执行程序。因此,政府对医疗器械的支持和报销政策的增加预计将支持医学成像市场。 COVID-19大流行对该地区国家的市场产生了积极影响。
< strong>市场概况与动态
亚太地区医学影像市场预计将从2021年的61.927亿美元增长到2028年的86.500亿美元;预计 2021 年至 2028 年复合年增长率为 4.9%。医学成像是诊断过程中不可或缺的一部分。从超声波到 MRI 和 CT 扫描,放射科医生利用医学成像来正确诊断和治疗疾病。此外,医生使用医学成像技术来确定特定疗法对于患者的治疗方法是否有效。在过去的几十年里,医学成像的能力呈放射状增长。由于基础研究和技术发展,医学成像技术取得了许多进步。这一进展对于提供准确的诊断和改善患者护理至关重要。这些进步,加上 IT 和数字技术的力量,提高了患者护理的提供和执行的程序效率。
从产品来看,X射线系统细分市场在2020年亚太医学影像市场中占据最大份额。从最终用户来看,医院2020年亚太地区医学影像市场占据最大份额。
准备本亚太地区医学成像市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括通用电气公司、西门子股份公司、荷兰皇家飞利浦公司、岛津制作所、日立有限公司、佳能公司、Hologic, Inc.、Carestream Health Inc.、ESAOTE SPA 和三星集团。
按产品
由最终用户
按国家/地区
Strategic insights for Asia Pacific Medical Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 6,192.7 Million |
Market Size by 2028 | US$ 8,650.0 Million |
Global CAGR (2021 - 2028) | 4.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Medical Imaging Market is valued at US$ 6,192.7 Million in 2021, it is projected to reach US$ 8,650.0 Million by 2028.
As per our report Asia Pacific Medical Imaging Market, the market size is valued at US$ 6,192.7 Million in 2021, projecting it to reach US$ 8,650.0 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.
The Asia Pacific Medical Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Imaging Market report:
The Asia Pacific Medical Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Imaging Market value chain can benefit from the information contained in a comprehensive market report.